InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.75
(
-0.87%
)
US TECH 100
16,646.00
(
-1.71%
)
Dow Jones
37,855.87
(
0.21%
)
Brent Oil
86.65
(
0.27%
)
Bitcoin
63,708.52
(
0.31%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: idcc2006 post# 27883

Sunday, 11/20/2016 12:50:28 PM

Sunday, November 20, 2016 12:50:28 PM

Post# of 30990
Was hoping we would get the Nilvad trial results before any attempt to sell the anatabine IP. Should Nilvadipine prove to be the first significant breakthrough towards a treatment for AD, and Dr. Mullan the lead person to commercialize that potential, it could get some extra attention for anatabine as he is the lead discoverer on that as well.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up